Article
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
8 Jul 2014
Abstract excerpt
The importance of intratumour genetic and functional heterogeneity is increasingly recognised as a driver of cancer progression and survival outcome. Understanding how tumour clonal heterogeneity impacts upon therapeutic outcome, however, is still an area of unmet clinical and scientific need. TRACERx (TRAcking non-small cell lung Cancer Evolution through therapy [Rx]), a prospective study of patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
